ETC
RLAY icon

Exchange Traded Concepts’s Relay Therapeutics RLAY Stock Holding History

Exchange Traded Concepts’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-36,293
Closed -$95.1K – 1487
2025
Q1 		$95.1K Buy
36,293
+15,644
+76% +$61.3K ﹤0.01% 1177
2024
Q4 		$85.1K Hold
20,649
– – ﹤0.01% 1174
2024
Q3 		$146K Sell
20,649
-5,951
-22% -$44.5K ﹤0.01% 1074
2024
Q2 		$173K Sell
26,600
-8,276
-24% -$56.5K ﹤0.01% 890
2024
Q1 		$289K Buy
34,876
+19,914
+133% +$194K 0.01% 811
2023
Q4 		$165K Buy
14,962
+3,794
+34% +$32K ﹤0.01% 816
2023
Q3 		$93.9K Sell
11,168
-899
-7% -$9.67K ﹤0.01% 918
2023
Q2 		$152K Buy
+12,067
New +$150K ﹤0.01% 838

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Exchange Traded Concepts's RLAY Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Relay Therapeutics (RLAY) in Q2 2025, closing a stake of 36,293 shares — an estimated $95.1K sold.

Exchange Traded Concepts first reported a position in RLAY in Q2 2023 and held it in 8 quarters. The position peaked at $289K in Q1 2024. 208 funds tracked by Wall St. Rank hold RLAY as of Q2 2025.

  • Exchange Traded Concepts reported no remaining Relay Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 36,293 Relay Therapeutics shares in Q2 2025, an estimated $95.1K.
  • Exchange Traded Concepts first reported a position in Relay Therapeutics in Q2 2023 and held it in 8 quarters.
  • Exchange Traded Concepts's Relay Therapeutics position peaked at $289K in Q1 2024.
  • 208 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.